Bogle Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Bogle Investment Management's GILD Position: Q2 2020 in Review
Bogle Investment Management sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 37,648 shares — an estimated $2.81M sold.
Bogle Investment Management first reported a position in GILD in Q2 2014 and held it in 17 quarters. The position peaked at $13.3M in Q3 2014. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.
- Bogle Investment Management reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
- Bogle Investment Management sold 37,648 Gilead Sciences shares in Q2 2020, an estimated $2.81M.
- Bogle Investment Management first reported a position in Gilead Sciences in Q2 2014 and held it in 17 quarters.
- Bogle Investment Management's Gilead Sciences position peaked at $13.3M in Q3 2014.
- 1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.
Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.